Study Evaluating the Safety and Efficacy of a Once-daily Dose of Tigecycline vs Ertapenem in Diabetic Foot Infections (DFI) With a Substudy in Patients With Diabetic Foot Infections Complicated by Osteomyelitis.

Completed · Phase 3

Conditions studied: Bacterial Infections, Diabetic Foot, Osteomyelitis

In brief

The purpose of this study was to look at the safety and effectiveness of a once-daily dose of tigecycline compared to ertapenem for the treatment of diabetic foot infections. The co-primary efficacy endpoints were not met.

Key facts

Study ID

NCT00366249

Run by

Wyeth is now a wholly owned subsidiary of Pfizer

People needed

1061

Starts

2007-01-01

Expected to finish

2009-03-01

Last updated by the study team

2010-04-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Study site — Los Angeles, California, United States
• Study site — Northridge, California, United States
• Study site — San Francisco, California, United States
• Study site — Sylmar, California, United States
• Study site — Torrance, California, United States
• Study site — Orlando, Florida, United States
• Study site — Orlando, Florida, United States
• Study site — Pensacola, Florida, United States
• Study site — West Palm Beach, Florida, United States
• Study site — Honolulu, Hawaii, United States
• Study site — Chicago, Illinois, United States
• Study site — Evanston, Illinois, United States
• Study site — North Chicago, Illinois, United States
• Study site — Springfield, Illinois, United States
• Study site — Springfield, Illinois, United States
• Study site — Baltimore, Maryland, United States
• Study site — Boston, Massachusetts, United States
• Study site — Somers Point, New Jersey, United States
• Study site — Winston-Salem, North Carolina, United States
• Study site — Lima, Ohio, United States
• Study site — Toledo, Ohio, United States
• Study site — West Reading, Pennsylvania, United States
• Study site — Columbia, South Carolina, United States
• Study site — Dallas, Texas, United States
• Study site — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.